- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vitrafy Life Sciences Ltd (VFY)
Vitrafy Life Sciences Ltd stock price live, this page displays ASX VFY stock exchange data. View the VFY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vitrafy Life Sciences Ltd real time stock price chart below.
What Is the Vitrafy Life Sciences Ltd Stock Price Today?
The Vitrafy Life Sciences Ltd stock price today is 3.18.
What Is the Stock Symbol for Vitrafy Life Sciences Ltd?
The stock symbol for Vitrafy Life Sciences Ltd is "VFY."
What Stock Exchange Does Vitrafy Life Sciences Ltd Trade On?
Vitrafy Life Sciences Ltd is listed and trades on the Sydney stock exchange.
Is Vitrafy Life Sciences Ltd a Good Stock to Buy?
Determining whether Vitrafy Life Sciences Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VFY quote. (ISIN: AU0000361297)
What Is the Vitrafy Life Sciences Ltd Stock Price Today?
The Vitrafy Life Sciences Ltd stock price today is 3.18.
What Is the Stock Symbol for Vitrafy Life Sciences Ltd?
The stock symbol for Vitrafy Life Sciences Ltd is "VFY."
What Stock Exchange Does Vitrafy Life Sciences Ltd Trade On?
Vitrafy Life Sciences Ltd is listed and trades on the Sydney stock exchange.
Is Vitrafy Life Sciences Ltd a Good Stock to Buy?
Determining whether Vitrafy Life Sciences Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VFY quote. (ISIN: AU0000361297)
Sydney
Currency in AUD
3.18
-0.02(-0.63%)
Closed·
Fair Value
An estimate of a Vitrafy Life Sciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.17
3.22
52 wk Range
1.16
3.87
VFY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Vitrafy Life Sciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.173.22
52 wk Range
1.163.87
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
VFY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Vitrafy Life Sciences's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
4.66
Upside
+46.41%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 4.66
(+46.41% Upside)
Vitrafy Life Sciences Ltd Earnings Call Summary for Q3/2026
- Vitrafy closed Q3 with AUD 18.5M cash, providing 12-18 month runway; receives AUD 600-700K quarterly grants through Q2 FY2027.
- Company completed Phase II testing for U.S. military blood platelet program; deployed Guardian cryopreservation units in France and U.S.
- FDA registration process for Guardian devices commenced; expected to unlock new market opportunities in H1 FY2025.
- Operational costs expected to rise in H2 due to manufacturing scale-up and team expansion; supply chain disruptions pose ongoing challenges.
- Stock trading near 52-week high at $1.43 with 55% YTD return; InvestingPro analysis suggests shares currently overvalued.
Last Updated: 28/04/2026, 01:14
Read Full TranscriptEarnings
Latest Release
Feb 03, 2026
EPS / Forecast
-0.11 / --
Revenue / Forecast
1.98M / --
Compare VFY to Peers and Sector
Metrics to compare | VFY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVFYPeersSector | |
|---|---|---|---|---|
P/E Ratio | −17.2x | −1.5x | −0.4x | |
PEG Ratio | −0.19 | −0.02 | 0.00 | |
Price/Book | 11.3x | 0.9x | 2.6x | |
Price / LTM Sales | 104.1x | 4.0x | 2.9x | |
Upside (Analyst Target) | 46.9% | 204.7% | 58.0% | |
Fair Value Upside | Unlock | 23.8% | 9.5% | Unlock |
Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. The company offers smart devices, such as smart cryopreservation, smart thawing, and smart packaging devices. It also provides a software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials under the LifeChain brand. The company’s cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs. Vitrafy Life Sciences Limited was incorporated in 2017 and is based in Melbourne, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Vitrafy Life Sciences (VFY) Stock Price Today?
The Vitrafy Life Sciences stock price today is 3.18 AUD.
What Stock Exchange Does Vitrafy Life Sciences Trade On?
Vitrafy Life Sciences is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Vitrafy Life Sciences?
The stock symbol for Vitrafy Life Sciences is "VFY."
What Is the Vitrafy Life Sciences Market Cap?
As of today, Vitrafy Life Sciences market cap is 242.31M AUD.
What Is Vitrafy Life Sciences's Earnings Per Share (TTM)?
The Vitrafy Life Sciences EPS (TTM) is -0.22.
From a Technical Analysis Perspective, Is VFY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Vitrafy Life Sciences Stock Split?
Vitrafy Life Sciences has split 0 times.
What is the current trading status of Vitrafy Life Sciences (VFY)?
As of Jul 27, 2026, Vitrafy Life Sciences (VFY) is trading at a price of 3.18 AUD, with a previous close of 3.18 AUD. The stock has fluctuated within a day range of 3.17 AUD to 3.22 AUD, while its 52-week range spans from 1.16 AUD to 3.87 AUD.
What Is Vitrafy Life Sciences (VFY) Price Target According to Analysts?
The average 12-month price target for Vitrafy Life Sciences is 4.66 AUD, with a high estimate of 5.1541976 AUD and a low estimate of 4.15762421 AUD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +46.41% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.